After announcing the biggest merger agreement for 2015, Pfizer announced Wednesday that the $160 billion merger with Ireland-based Allergan PLC would not proceed in light of new regulations passed by the U.S. Department of Treasury that curb tax-avoiding corporate mergers. The regulations were passed Monday, and an announcement from Pfizer was widely expected Wednesday.
